Enhancer RNAs (eRNAs) are non-coding RNA molecules transcribed directly from DNA enhancer regions. Their primary function is to activate and fine-tune gene expression. They regulate both neighboring genes (cis-regulation) and distant genes (trans-regulation) by controlling chromatin structure and transcription machinery. 

eRNAs accomplish this through several key molecular mechanisms: 

• Stabilizing Chromatin Loops: eRNAs act as structural scaffolds that physically bridge the distance between an enhancer and a target gene promoter, creating a functional loop. 
• Recruiting Transcription Factors: They act as molecular decoys or traps that bind and concentrate key transcription factors, preventing them from diffusing and increasing their residency time at the target site.
• Facilitating Pause Release: eRNAs help RNA Polymerase II overcome “pausing,” transitioning it into the productive elongation phase required to actually produce messenger RNA (mRNA). 
• Modifying Chromatin: They interact with histone acetyltransferases (such as CBP) to alter chromatin accessibility, making the local DNA more open and active for transcription. 
• Phase Separation: eRNAs help form dense, liquid-like transcriptional hubs that collect the proteins and machinery needed for rapid gene expression. 

Because eRNAs are highly tissue-specific and dictate cell fate, their dysregulation is frequently implicated in the development of cancers and other diseases, making them prominent targets for biological therapy and biomarker discovery.